YOUR SEARCH :
Industry: Health Care and Social Assistance
YOUR SEARCH PRODUCED 250 MATCHES. PAGE 1 of 26 Items 1-10 of 250
Author: Friedman, Milton
Product Type: Essays and Concept Papers; Magazine / Newspaper Articles; Speeches
Source: The New York Times Magazine, September 13, 1970.
Publication Year: 1970
"When I hear businessmen speak eloquently about the "social responsibilities of business in a free-enterprise system," it's obvious that they believe that they are defending free enterprise
Authors: Chu, Michael; Garcia-Cuellar, Regina
Product Type: Cases
Source: Harvard Business School Publishing
Publication Year: 2007
This case profiles a retail model for low-income markets and examines the role of private enterprise and profits in the health care of low-income populations, the creation of social value in commercial enterprises, and possible implications for public policy.
Authors: Mitchell, Ronald K.; Agle, Bradley R.; Wood, Donna J.
Product Type: Journal Articles
Source: Academy of Management Review 1997, Volume 22, No. 4, pp. 853-886
Publication Year: 1997
This discussion of stakeholder theory argues that stakeholders possess one or more of three relationship attributes: power, legitimacy and urgency.
Author: Rangan, V. Kasturi
Product Type: Cases
Source: Harvard Business School
Publication Year: 2007
Starting as a modest 20-bed hospital, Aravind had grown into a 1,400-bed hospital complex by 1992. It had by then screened 3.65 million patients and performed 335,000 cataract surgeries, nearly 70% of them free of cost for the poorest of India's blind population...
Authors: Ellison, Brian; Rodriguez, Miguel A.
Product Type: Cases
Source: IESE Business School
Publication Year: 2003
This case series deals with the pioneering experience of Unilever at the "base of the pyramid" (BOP). The BOP consists of those 4 billion people excluded from the market economy and living in poverty. The BOP is a new management concept that conveys the promise to fulfill a twofold objective: promote social development and allow companies to regain double digit growth rates.
Authors: Spar, Debora L.; Bartlett, Nicholas
Product Type: Cases
Source: Harvard Business School Publishing
Publication Year: 2005
This case was analyzed for the 2003 Walter V. Shipley Business Leadership Case Competition. In the final years of the 20th century, the world was hit by a plague of epidemic proportions--AIDS, a life-threatening disease that remained stubbornly immune to any cure or vaccine
Authors: Bhattacharya, C.B.; Sen, Sankar
Product Type: Journal Articles
Source: California Management Review
Publication Year: 2004
Although companies are devoting significant resources to corporate social responsibility (CSR) initiatives, insights into the optimal formulation, implementation, and effectiveness estimation of CSR strategies are currently scarce. This article takes an in-depth look at when, why, and how CSR works from a consumer's perspective...
Author: Walsh, Mary Williams
Product Type: Magazine / Newspaper Articles
Source: The New York Times
Publication Year: 2008
When Cynthia Fitzgerald started out in pharmaceutical sales 20 years ago, she received ample training on the right and wrong ways to sell medical products. Those early lessons didn't serve her so well when she went to work in health care purchasing. Eventually, Ms. Fitzgerald decided to file what could become one of the largest whistle-blower lawsuits on record.
Authors: Yaziji, M.; Lindblom, A.
Product Type: Cases
Source: International Institute for Management Development
Publication Year: 2005
The case describes the interactions among pharmaceutical companies, non-government organisations (NGOs), and governments in the context of the AIDS epidemic in South Africa.
Authors: Deshpande, Rohit; Winig, Laura
Product Type: Cases
Source: Harvard Business School Publishing
Publication Year: 2006
The head of Cipla, a $325-million-dollar Indian pharmaceutical company and seller of low-cost AIDS drugs to South Africa, must decide what to do about Cipla's future. With India poised to enforce international patents in only two years, much of Cipla's product line could become unsaleable...
YOUR SEARCH PRODUCED 250 MATCHES. PAGE 1 of 26 Items 1-10 of 250